Issues & Insights

What We’re Reading Today: Economic Damage, Hydroxychloroquine Helps, Waffle House Index … And More

Some headlines that caught our eye.

Economic figures show grim toll in Europe and U.S. from virus — Associated Press

Blood clots, skin lesions identified among possible COVID-19 symptoms — United Press International

Gilead to work with partners to ramp up production of potential coronavirus treatment — Reuters

Density Debate is Shifting Ground Because of the Pandemic — Joel Fox, Fox & Hounds

Physicians Say Hospitals Are Pressuring ER Docs to List COVID-19 on Death Certificates – Here’s Why — Foundation for Economic Education

Economics, a San Francisco Treat? — Veronique de Rugy, Creators Syndicate

No COVID-19 Spike from Wisconsin’s In-Person Voting — National Review

Hydroxychloroquine Has about 90% Chance of Helping COVID-19 Patients — Association of American Physicians and Surgeons

Fauci On Remdesivir Trial: ‘Clearly Positive’ But ‘Modest’; A ‘First Step’ To ‘Better Drugs’ — The Daily Wire

New York Paid $69 Million to a Shady Vendor for Ventilators That Were Never Delivered — Christian Britschgi, Reason

Waffle House shows the emergency over — Don Surber

Were excess deaths merely shifted? — Arnold Kling

Recovered patients who tested positive for COVID-19 likely not reinfected — Live Science

What Will It Take To Achieve COVID-19 Herd Immunity? — American Council on Science and Health

Some Governors Are Getting Serious About The Cost Of Coronavirus Lockdowns. Some Aren’t — John Daniel Davidson, Federalist

The surprising popularity of the Great Lockdown — The Hill

Trump Denies COVID-19 Funds to Planned Parenthood — The Daily Signal

We Could Use Your Help

Issues & Insights was founded by seasoned journalists of the IBD Editorials page. Our mission is to provide timely, fact-based reporting and deeply informed analysis on the news of the day -- without fear or favor.

We’re doing this on a voluntary basis because we believe in a free press, and because we aren't afraid to tell the truth, even if it means being targeted by the left. Revenue from ads on the site help, but your support will truly make a difference in keeping our mission going. If you like what you see, feel free to visit our Donations Page by clicking here. And be sure to tell your friends!

You can also subscribe to I&I: It's free!

Just enter your email address below to get started.

Share

I & I Editorial Board

The Issues and Insights Editorial Board has decades of experience in journalism, commentary and public policy.

About Issues & Insights

Issues & Insights is run by the seasoned journalists behind the legendary IBD Editorials page. Our goal is to bring our decades of combined journalism experience to help readers understand the top issues of the day. We’re doing this on a voluntary basis, because we believe the nation needs the kind of cogent, rational, data-driven, fact-based commentary that we can provide. 

We Could Use Your Help

Help us fight for honesty in journalism and against the tyranny of the left. Issues & Insights is published by the editors of what once was Investor's Business Daily's award-winning opinion pages. If you like what you see, leave a donation by clicking on donate button above. You can also set up regular donations if you like. Ad revenue helps, but your support will truly make a difference. (Please note that we are not set up as a charitable organization, so donations aren't tax deductible.) Thank you!
Share
%d bloggers like this: